Discontinuation report FLUZONE HIGH-DOSE
| Report ID | 134564 |
| Drug Identification Number | 02445646 |
| Brand name | FLUZONE HIGH-DOSE |
| Common or Proper name | Influenza Virus Vaccine Trivalent Types A and B (Split Virion) |
| Company Name | SANOFI PASTEUR LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN B |
| Strength(s) | 60MCG 60MCG 60MCG |
| Dosage form(s) | SUSPENSION SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 x 0.5 mL (single dose) syringes without attached needle |
| ATC code | J07BB |
| ATC description | VIRAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-11-06 |
| Actual discontinuation date | 2020-11-06 |
| Remaining supply date | 2020-11-20 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Sanofi Pasteur Limited is launching Fluzone® High-Dose Quadrivalent for 2021/22 influenza season. FLUZONE Fluzone® High-Dose Trivalent has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-02-22 | English | Compare |
| v2 | 2021-02-22 | French | Compare |
| v3 | 2021-03-11 | English | Compare |
| v4 | 2021-03-11 | French | Compare |
Showing 1 to 4 of 4